| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |